Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis

Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis

Background The angiotensin‐receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be superior to the angiotensin‐converting enzyme inhibitor enalapril in terms of reducing cardiovascular mortality in the PARADIGM‐HF (Prospective Comparison of ARNI with angiotensin‐converting enzyme i...

Full description

Bibliographic Details
Main Authors: Yiwen Wang, Ran Zhou, Chi Lu, Qing Chen, Tongda Xu, Dongye Li
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
angiotensin‐receptor neprilysin inhibitor
cardiac reverse remodeling
end‐diastolic dimension
heart failure with a reduced ejection fraction
meta‐analysis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.012272

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.012272

Similar Items